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The need for emergency surgical treatment in
carotid-related stroke in evolution and crescendo
transient ischemic attack
Laura Capoccia, MD,a Enrico Sbarigia, MD,a Francesco Speziale, MD,a Danilo Toni, MD,b
Antonella Biello, MD,a Nunzio Montelione, MD,a and Paolo Fiorani, MD,a Rome, Italy
Objective: The purpose of this study was to examine the safety of emergency carotid endarterectomy (CEA) in patients
with carotid stenosis and unstable neurological symptoms.
Methods: This prospective, single-center study involved patients with stroke in evolution (SIE) or fluctuating stroke or
crescendo transient ischemic attack (cTIA) related to a carotid stenosis >50% who underwent emergency surgery.
Preoperative workup included National Institute of Health Stroke Scale (NIHSS) neurological assessment on admission,
immediately before surgery and at discharge, carotid duplex scan, brain contrast-enhanced head computed tomography
(CT) or magnetic resonance imaging (MRI). End points were perioperative (30-day) neurological mortality, NIHSS
score variation, and hemorrhagic or ischemic stroke recurrence. Patients were evaluated according to clinical presentation
(SIE or cTIA), timing of surgery, and presence of brain infarction on neuroimaging.
Results: Between January 2005 and December 2009, 48 patients were submitted to emergency surgery. CEAs were
performed from 1 to 24 hours from onset of symptoms (mean, 10.16 7.75). Twenty-six patients presented an SIE with
a worsening NIHSS score between admission and surgery, and 22 presented >3 cTIAs with a normal NIHSS score (
0) immediately before surgery. An ischemic brain lesion was detected in four patients with SIE and eight patients with
cTIA. All patients with cTIA presented a persistent NIHSS normal score before and after surgery. Twenty-five patients
with SIE presented an NIHSS score improvement after surgery. Mean NIHSS score was 5.30 2.81 before surgery and
0.54  0.77 at discharge in the SIE group (P < .0001). One patient with SIE had a hemorrhagic transformation of an
undetected brain ischemic lesion after surgery, with progressive neurological deterioration and death (2%).
Conclusions: Due to the absence of randomized controlled trials of CEA for neurologically unstable patients, data
currently available do not support a policy of emergency CEA in those patients. Our results suggest that a fast protocol,
including CT scans and carotid duplex ultrasound scans in neurologically unstable patients, could help identify those that
can be safely submitted to emergency CEA. (J Vasc Surg 2012;55:1611-7.)
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sIn previous years, ischemic stroke treatment has gained
more and more attention worldwide because of imaging
technique improvements and the development of new
treatment strategies such as fibrinolytic therapy.
The immediate management of a patient presenting
with a suspected acute focal neurological syndrome follows
published guidelines for emergency stroke care.1 Once the
diagnosis of acute ischemic stroke is established, the patient
has been stabilized, thrombolytic therapy has been admin-
istered to an eligible patient, and initial preventive therapy
has been implemented, further evaluation is directed to-
ward establishing the vascular territory involved and the
From the Vascular Surgery Division, Department of Surgery “Paride Stefa-
nini”,a and Stroke Unit, Department of Emergency,b Policlinico Um-
berto I, “Sapienza” University of Rome.
Author conflict of interest: none.
Presented at the 2011 Vascular Annual Meeting of the Society for Vascular
Surgery, Chicago, Ill, June 16-18, 2011.
Reprint requests: Laura Capoccia, MD, Vascular Surgery Division, Depart-
ment of Surgery “Paride Stefanini,” Policlinico Umberto I, “Sapienza”
University of Rome 155, viale del Policlinico, 00161 Rome, Italy (e-mails:
lauracapoccia@yahoo.it; lauracapoccia3@gmail.com).
The editors and reviewers of this article have no relevant financial relationships
to disclose per the JVS policy that requires reviewers to decline review of any
manuscript for which they may have a conflict of interest.
0741-5214/$36.00t
Copyright © 2012 by the Society for Vascular Surgery.
doi:10.1016/j.jvs.2011.11.144ause and pathophysiology of the event.1-4 Such evalua-
ions must be offered as soon as possible in order to
romptly start therapeutic maneuvers.
In patientswhodisplay ischemic symptoms in the territory
f a carotid artery that has high-grade stenosis, surgical inter-
ention reduces the risk of major neurological events.5,6
There is increasing evidence that carotid endarterec-
omy (CEA) after an ischemic cerebrovascular event can
afely be performed within a shorter waiting period than in
he past years,7 with the aim of reducing brain cells loss by
romptly restoring blood flow in the ischemic penumbra.8
The benefit of CEA in preventing stroke is greatly
iminished beyond 2 weeks after the onset of symptoms, in
arge part because the risk of recurrent ischemic events is
ighest in this early period. After 4 weeks in women and 12
eeks in men, the benefit of surgery in these symptomatic
atients is no more than that observed with surgery for
symptomatic patients, and in some cases surgery may be
armful.9 Some physicians question the higher periopera-
ive complication rates in those patients when compared to
enerally called “symptomatic patients.” Nevertheless,
ome protocols have proven to be effective in preventing
troke recurrence in experienced hands.10,11
As reported in those studies,10,11 in neurologically
table patients, CEA has proven to be effective in reducing
he risk of recurrent events with low intraoperative stroke
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June 20121612 Capoccia et alrates. On the other hand, main concern exists on the risk of
hemorrhagic transformation or conversion of the brain
lesion in patients presenting with unstable neurological
symptoms, such as crescendo transient ischemic attack
(cTIA) and stroke in evolution (SIE).
Unstable patients have a higher surgical risk in an
emergency setting because of the high carotid plaque insta-
bility and the repeated brain insults, thus the increased
brain vulnerability. For many years, complication rates de-
tected in unstable patient studies have been the highest
reported. Recently, some authors have demonstrated that
in unstable patients emergency revascularization complica-
tion rates are quite acceptable after a strict patient selection
andmanagement protocol.12-14 Currently, the consensus is
lacking if unstable patients could benefit from an emer-
gency revascularization procedure.
This study was undertaken to evaluate the benefit of
emergency carotid revascularization by CEA in patients
with carotid disease and unstable neurological symptoms
(cTIA and SIE) given a predefined management protocol.
METHODS
Patient population and treatment protocol. This
prospective, single-center study involved patients with
stroke in evolution or fluctuating stroke (SIE) or cTIA
related to a carotid stenosis 50% who underwent surgery
within 24 hours from the onset of neurological symptoms
at our academic center. All patients gave their written
informed consent before urgent CEA. The protocol was
approved by the local ethical committee. From January
2005 to December 2009, 22,666 patients presented to our
emergency department with neurological symptoms and
were evaluated by a neurologist who established the initial
neurologic severity and stability. All patients followed a
standardized evaluation protocol. For each patient, age,
sex, body weight, history of hypertension, hypertension on
admission (systolic 160 mm Hg or diastolic 90 mm
Hg), history of coronary artery disease and/or diabetes
mellitus, atrial fibrillation on admission, stroke severity on
admission (as assessed by National Institutes of Health
Stroke Scale [NIHSS]), level of consciousness on admis-
sion, time from onset of symptoms to hospital admission,
blood tests, and anticoagulant or antiplatelet treatment
were recorded. Whenever an ischemic or hemorrhagic brain
insult was suspected, the patient promptly underwent cerebral
computed tomography (CT) or magnetic resonance imaging
(MRI) to assess the presence, nature, and extent of eventual
brain lesions. After exclusion of brain hemorrhage, a carotid
duplex ultrasound scan was performed and low-molecular-
weight heparin was administered according to body weight.
When a carotid plaque causing a70% stenosis or an irregular
or ulcerated carotid plaque causing a 50% stenosis was
encountered, patency of middle cerebral artery (MCA – M1
andM2portions)was assessedby transcranialDoppler (TCD)
scan, whenever possible, or by contrast-enhanced cerebral CT
scans. According to inclusion and to clinical and imaging
exclusion criteria, as listed in Table I, patients were subse-
quently submitted to emergency CEA. A cTIAwas defined as depeatedTIAswithin a relatively short periodof time.On each
ccasion, the patient had a full recovery of the neurological
eficit before the new event that was more severe than the
revious one. SIE was defined as an increasingly worsening or
uctuating neurological deficit with no restoration of the
eurologic status between episodes. Forty-eight patients were
ubmitted toCEAof 71 patients presenting to the emergency
epartment with a carotid stenosis50% and unstable neuro-
ogical symptoms (67% of patients presenting with unstable
ymptoms and carotid stenosis, 0.2% of those presenting at
ur emergency department with neurological symptoms). In
3 patients, the presence of a huge ischemic lesion on CT
cans (attenuation of density, sulcal effacement, or ventricular
ompression) prevented an expeditious treatment. All patients
ubmitted to surgery received at least three NIHSS assess-
ents, on admission, immediately before surgery, and at
ischarge.
Perioperative management. Routine physiological
onitoring included pulse oximetry, electrocardiogram,
nd invasive blood pressure measurement via radial artery.
efore clamping the internal carotid artery (ICA) a dose of
eparin (5000 2000 IU, depending on body weight) was
njected intravenously. Neurological status assessment was
erformed using the near-infrared spectroscopy (NIRS)
nd TCD whenever possible throughout the entire proce-
able I. Inclusion and exclusion criteria for patient
nrolment
nclusion criteria
Clear time of onset of symptoms
NIHSS score 22
Recent ischemic hemispheric brain infarct 1/3 of the middle
cerebral artery area regardless of BBB disruption at CT or
MRI scans
ICA stenosis 70% or 50% with an ulcerated surface plaque
at ultrasound scan evaluation
Patent middle cerebral artery in the detectable portion M1 and
M2
xclusion criteria
ccording to clinical presentation on admission
Not clear time of onset of symptoms
Severe neurological deficit (NHISS score 22)
Cerebral ischemia onset with seizures
Previous ischemic or hemorrhagic stroke with residual severe
deficit (modified Rankin scale 2)
History of cerebral hematomas
Any other cerebral disease with residual permanent deficit
ccording to CT or MRI scans on admission
Recent ischemic hemispheric brain infarct 1/3 of the middle
cerebral artery area
Presence of cerebral hemorrhage
Brain tumor
Cerebral arteriovenous malformation
Cerebral aneurysm
BB, Blood-brain barrier;CT, computed tomography; ICA, internal carotid
rtery; MRI, magnetic resonance imaging; NIHSS, National Institute of
ealth Stroke Scale.ure. CEA was performed by standard surgical protocol in
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Volume 55, Number 6 Capoccia et al 1613all cases. A shunt was used when a 50% reduction in the
MCA mean velocity at TCD monitoring or a20% reduc-
tion of regional oxygen saturation at NIRS monitoring was
detected.
In the postoperative period, patients were maintained
under a low dosage of heparin (4000 IU enoxaparin so-
dium) together with their scheduled medicaments. Systolic
blood pressure was maintained below 140 mm Hg in the
immediate postoperative period. At discharge, antiplatelet
therapy (acetylsalicylic acid 100 mg daily) was started. All
patients were evaluated by an experienced neurologist im-
mediately after surgery and at discharge with recording of
any neurological adverse event and NIHSS score assess-
ment. All patients were submitted to CT scans before
discharge.
End points and statistical analysis. Perioperative (30-
day) neurological mortality, NIHSS score variation (in-
crease or decrease), and hemorrhagic or ischemic stroke
recurrence were considered primary end points. Cardiac or
pulmonary complications such as wound or cervical nerve
injuries were considered secondary end points and recorded
for each patient.
Patients were evaluated according to clinical presenta-
tion (SIE or cTIA), clinical and demographic characteris-
tics, timing of surgery, and the presence of brain infarction
on neuroimaging. Univariate analysis was performed by
Mann-Whitney test for continuous variables, and results are
expressed as mean  SD, and the 2 and Fisher exact tests
were used for categorical variables and are expressed as
numbers and percentages. A value of P  .05 was consid-
ered statistically significant.
RESULTS
Between January 2005 and December 2009, 48 pa-
tients presenting to the emergency department with a
carotid stenosis 50% and unstable neurological symp-
toms were submitted to urgent CEA. Surgery was per-
Table II. Preoperative variables
cTIA (n  22)
Male gender 19
Age 74.2  6.8
Hypertension 14
Diabetes 4
Smoker 11
Hyperlipemia 4
Ischemic brain lesion on CT scans 8
NIHSS before surgery 0
Stenosis percentage
51% to 70% 3
71% to 90% 9
91% to 99% 10
Occlusion 0
Carotid plaque composition
Hyperechoic 8
Hypo-anechoic 14
CT, Computed tomography; cTIA, crescendo transient ischemic attack; NIformed from 1 to 24 hours from onset of symptoms fmean, 10.16  7.75 hours). Twenty-six patients pre-
ented a worsening NIHSS score between admission and
urgery and were classified as SIE, and 22 presented
hree or more TIAs with a complete recovery before
urgery (NIHSS  0) and were classified as cTIA. Forty
atients were men (83.3%) and eight patients were
omen (16.7%). Mean age was 72.5 8.3 years. Hyper-
ension was detected in 30 patients (62.5%), diabetes in
0 patients (20.8%), hyperlipemia in 10 patients
20.8%), and smoking habitus in 26 patients (54.2%).
An ischemic brain lesion was detected in 12 of these
atients (25%), SIE in four patients, and cTIA in eight
atients. No significant differences were found in the two
linical groups in carotid plaque composition or stenosis
ercentage. In one patient with SIE, a complete thrombo-
is of the ICA was encountered intraoperatively (Table II).
Locoregional anesthesia was used in 14 cases (29.2%)
nd general anesthesia in 34 (70.8%) with TCDmonitoring
n 24 (50%) and NIRS monitoring in 24 (50%). In three
ases (6.2%), CEA was performed with standard technique
nd direct closure, in 37 cases (77.1%) with patch closure,
n 7 cases (14.6%) with eversion technique, and in one case,
common-internal carotid bypass was implanted (2%). In
2 patients (five patients with cTIA and seven patients with
IE; 25%), a shunt was used during endarterectomy be-
ause of TCD and NIRS monitoring in eight and four
ases, respectively (Table III). All patients with cTIA pre-
ented a persistent NIHSS normal score ( 0) before and
fter surgery.
Twenty-five patients with SIE presented an NIHSS
core improvement after surgery. Mean NIHSS score was
.23 1.31 on admission, 5.30 2.81 before surgery, and
.54  0.77 at discharge in the SIE group (P  .0001;
ig).
In one patient with SIE, a hemorrhagic transformation
f an undetected brain ischemic lesion was noted after
urgery with a progressive neurological deterioration in the
entage SIE (n  26) Percentage P value
6.4 21 80.8 .45
70.7  9.3 .14
3.6 16 61.5 .56
8.2 6 23.1 .26
0 15 57.7 .20
8.2 6 23.1 .26
6.4 4 15.4 .09
5.30  2.81 —
3.6 7 26.9 .15
0.9 8 30.8 .33
5.4 10 38.5 .20
1 3.8 .54
6.4 10 38.5 .23
3.6 16 61.5 .56
ational Institute of Health Stroke Scale; SIE, stroke in evolution.Perc
8
6
1
5
1
3
1
4
4
3
6ollowing 24 hours and death (2%).
r
C
r
r
a
f
i
1
ansfo
JOURNAL OF VASCULAR SURGERY
June 20121614 Capoccia et alLogistic regression analysis showed no statistically sig-
nificant association between NIHSS score decrease and
time of intervention or age in patients with SIE (P  .68
and .44, respectively). Major and minor complications are
listed in Table IV.
DISCUSSION
In the last 10 years, Rothwell et al15-17 published
different articles on indication to CEA in relation to clinical
Table III. Intraoperative variables
cTIA (n  22)
Cervical block 4
General anesthesia 18
Neurological status monitoring
TCD 10
NIRS 12
CEA
Patch closure 16
Direct closure 1
CEA-eversion technique 5
Common-internal carotid bypass 0
Shunt 5
CEA, Carotid endarterectomy; cTIA, crescendo transient ischemic attack;
Doppler.
Fig. National Institutes of Health Stroke Scale (NIHSS
after surgery (patient died of hemorrhagic brain lesion tr
Table IV. Perioperative complications
Total
number
Major complicatio
Stroke
recurrence
Hemorrhagic
conversion
SIE 26 0 1
cTIA 22 0 0
cTIA, Crescendo transient ischemic attack; SIE, stroke in evolution.presentation and timing of surgery. sIn a meta-analysis published in 2003, Bond et al18
eported data on the risk of stroke and death resulting from
EA in subset of asymptomatic and symptomatic patients
eported in studies published up to 2000. In the 95 studies
eporting the risk of CEA in 36,482 patients for symptom-
tic stenosis, the absolute risk of stroke and death ranged
rom 2.8 (95% confidence interval [CI], 2.2-3.4; 18 stud-
es) for CEA for ocular events only to 19.2% (95% CI,
0.7-27.8; 12 studies) for surgery for ongoing cerebral
ntage SIE (n  26) Percentage P value
.2 10 38.5 .08
.8 16 61.5
.19
.5 14 53.8
.5 12 46.2
.7 21 80.8 .22
.5 2 7.7 .41
.7 2 7.7 .14
1 3.8 .54
.7 7 26.9 .25
, near-infrared spectroscopy; SIE, stroke in evolution; TCD, transcranial
re in patients with stroke in evolution (SIE) before and
rmation excluded).
Minor complications
Myocardial
infarction
Wound
complications
Temporary cervical
nerve palsy
0 0 0
0 0 1Perce
18
81
45
54
72
4
22
22
NIRS) sconsymptoms. The highest operative risks were reported in
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Volume 55, Number 6 Capoccia et al 1615studies of surgery for SIE, cTIA, and cases that were simply
termed “urgent.” Thirteen studies reported data on those
groups showing a higher operative risk in urgent cases, even
if the number of cases reported in each study was small. The
combined relative odds of operative stroke and death re-
sulting from surgery for these urgent indications vs nonur-
gent surgery was 4.9 (95% CI, 3.4-7.1; P .001). So Bond
et al18 concluded that, even if SIE and cTIA have a rela-
tively poor prognosis on medical treatment alone, the
number of studies included in the meta-analysis was rela-
tively small and the definitions of urgent surgery varied
among studies; in these patients, the available data do not
support a policy of CEA in the acute phase.
A systematic review analyzing CEAs in patients with
SIE or cTIA in the last 23 years published by Karkos et al19
in 2009 showed a stroke/death perioperative rate after
CEA for cTIA of 6.5% and 9%, respectively, and 16.9% and
20.0% for SIE. The authors concluded that the combined
risk of neurological and cardiac complications in those
patients is higher than that anticipated after elective surgery
for stable symptoms. However, the series analyzed reported
on a small number of patients over a long period of time,
usually grouping all “urgent” indications together so that a
satisfactory meta-analysis was prevented. Moreover, the
new diagnostic modalities, the easier access to dedicated
stroke units, and the closer collaboration between special-
ists involved in stroke treatment showed better results in
urgent CEAs in the most recent series so they will definitely
improve future outcomes.
The preoperative workup seems to be crucial to the
outcome of urgent CEAs in patients with unstable neuro-
logical symptoms. A fast management of neurologically
unstable patients involving early assessment of presence and
extension of brain lesions by CT scans, presence and char-
acteristics of carotid plaque by duplex ultrasound scans, and
patency ofMCA by TCDor contrast-enhanced CT scans, is
mandatory in order to offer the earliest treatment. In our
study, we were able to maintain a low major complication
rate because of a strict collaboration among stroke special-
ists and a quick protocol that has proven to be effective in
previous reports by our group.10,13 Patients included in
this study presented with low-moderate neurological im-
pairment (mean NIHSS score, 2.23  1.31 on admission
and 5.30 2.81 before surgery in patients with SIE) and a
brain infarction 1/3 of the middle cerebral artery terri-
tory.20 About two thirds of the patients were included in
the study and submitted to expedite surgery with a mean
time between admission and intervention of 10 hours
and treatment within 24 hours in all of them. Excluded
patients presented brain infarctions that prevented a safe
treatment of the carotid stenosis. The urgent CEAs per-
formed in our patients have rapidly deleted a source of
ongoing embolism and rescued flow-impaired brain areas
(ischemic penumbra).21 The key points of our protocols are
evident from the exclusion criteria listed in Table I. Neu-
rologically unstable patients are classified and then submit-
ted to surgery according to clinical and anatomical or
imaging criteria. The consciousness and the relatively small Frain infarction area are basic requirements to offer emer-
ency CEA to patients. Particularly, anatomical criteria
oncerning the MCA area are derived from previous obser-
ational studies and randomized trials on thrombolytic
herapy in stroke patients.22 Moreover, the easiness of use
nd good reproducibility of NIHSS neurological score have
llowed treatment of patients with mild and moderate
eurological impairment with good outcomes. In the SIE
roup, the shorter interval between admission and surgery
ould explain the lower rate of brain infarcts detected on
euroimaging, with a persistent lower rate in the postoper-
tive period. In the present series, the only major neurolog-
cal complication occurred in a patient whose brain isch-
mic lesion remained undetected, and he had hemorrhagic
ransformation and finally death.
Because of the necessity of a quick diagnosis and the
nstable character of neurological symptoms in those pa-
ients, CT scans were mainly used instead of the more
ccurate diffusion-weighted imaging (DWI) to diagnose
ery early ischemic lesions. Nevertheless, the reported pro-
ocol, including mainly CT scans, performed quite well in
he emergency setting.
In a recent report by Merwick et al23 on the validation
f the ABCD2 score in patients at early risk of stroke after
IA, the series included for analysis were mainly evaluated
y CT scans instead of MRI scans. However, the use of
RIs should be encouraged because of its higher sensitiv-
ty in ischemic brain lesions. TIA is associated with high risk
f early recurrent stroke, with stroke rates as high as 35% in
ome subgroups by 7 days.16,23 The presence of carotid
tenosis and acute DWI hyperintensity in patients with a
revious TIA are highly sensitive for identification of those
t high risk of stroke as early as 2 days after assessment. So
very effort in order to prioritize carotid imaging after TIA
nd urgent CEA,24-26 whenever possible, should be em-
hasized as shown by recent guidelines.23,27,28 In the
cute-stroke phase, stroke outcome can be greatly influ-
nced by numerous factors, such as recanalization, evolving
troke, reperfusion injury, and collateral circulation. As
eported by Wong et al,29 different factors could influence
utcome in the subacute-stroke phase such as age, presence
f previous stroke, DWI lesion volume, andNIHSS score at
days, so the possibility to decrease the NIHSS score in the
rst 7 days after the event can deeply affect long-term
utcome in stroke patients. Close collaboration among
troke specialists is mandatory in order to offer the quickest
trategy to patients presenting with acute neurologic
vents. Clinical neurologic assessment is crucial to the
pplication of recommendations for selection of patients
or CEA, which includes estimation of perioperative stroke
isk. In a meta-analysis of nearly 16,000 symptomatic pa-
ients undergoing CEA, the 30-day risk of stroke or death
as 7.7%when a neurologist evaluated the patient and 2.3%
hen a vascular surgeon performed the evaluation.30 These
ata show a threefold increase in reported events when
ndependent adjudication is used and support a policy of
valuation by a neurologist for patients undergoing CEA.
urthermore, collaboration among specialists is crucial to
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The possibility to offer early CEA after intravenous throm-
bolysis in stroke-eligible patients, as usually performed by
our group, further broadens the benefit of treatment and
reinforces the need for collaboration.
Results from meta-analysis and systematic reviews on
major series reporting on urgent CEA seem quite discour-
aging, advocating for new randomized controlled trials to
prove the efficacy and benefit of urgent treatment in unsta-
ble neurological patients. Nevertheless, some management
protocols in patients with acute neurological symptoms
have proven to be effective with low complication rates
when administered by experienced practitioners that had
taken the chance to go on and operate on those patients to
prevent stroke recurrence and treat brain flow impairment.
The timing of the onset of neurological symptoms, the
rapid examination with the use of the NIHSS to quantify
the deficit, and the eventual detection of a focal area of low
density that involves more than one third of the MCA
territory seem to be the basic requisites to decide when
emergency CEA can be safely performed. Therefore, we
need more randomized trials to demonstrate that urgent
CEA can avoid more deaths or disabilities, that are in the
order of 14% to 18% and 31% to 71%, respectively,18,31,32
than hundreds of CEAs in asymptomatic patients.33
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The article by Capoccia et al addresses a critical question in the
treatment of carotid-related stroke. Appropriate timing of endar-
terectomy after an ischemic stroke or transient ischemic attack has
not been conclusively established. In the past, endarterectomy has
been delayed to avoid the devastating complications of hemor-
rhage and edema into the pre-existent infarct, thereby extending
the stroke.
A waiting period of 6 to 12 weeks has been advocated in the
past to decrease the incidence of reperfusion injury or hemorrhage
into the area of the ischemic tissue. However, it has been recog-
nized that most recurrent strokes occur shortly after the initial
event, thereby decreasing the window for beneficial intervention to
actually reduce the risk of a second more disabling stroke.1
Reperfusion injury has been minimized as knowledge about
the pathogenesis of ischemic stroke has increased. Unfortu-
nately, the landmark prospective trials regarding carotid endar-
terectomy, the North American Symptomatic Carotid Endar-
terectomy Trial and the European Carotid Surgery Trial, do not
shed light on this issue, enrolling patients up to 6 months after
presentation without commenting on timing of the intervention
in regard to initial symptoms.
Therefore, attempts such as those made by the authors are
important to maximize the benefit of endarterectomy to reduce
stroke. Guidelines from the American Heart Association and
American Stroke Association support rapid intervention after the
development of ischemic symptoms.2 Citing level B evidence, the
most recent guidelines state that “benefit from surgery was greatestuidelines note that recurrent stroke is most frequent within the
rst several weeks after symptoms and that delay beyond that
eriod returns patients to a baseline level of risk. However, the
ssue remains controversial. Experiences, such as those reported by
ockman et al,3 have noted an increased rate of perioperative
omplications for patients undergoing endarterectomy 4 weeks
f symptoms compared with those treated in a more delayed
ashion.
The current article emphasizes an important point: When
troke is treated in an organized stroke center with a protocol for
valuation by neurology and vascular surgery, good results can be
btained with rapid intervention. Such collaboration leads to
roper patient selection and is critical to obtain results that further
efine the benefit of carotid endarterectomy for stroke prevention.
EFERENCES
. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ,
Carotid Endarterectomy Trialists Collaboration. Endarterectomy for
symptomatic carotid stenosis in relation to clinical subgroups and timing
of surgery. Lancet 2004;363:915-24.
. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, et al.
Guidelines for the prevention of stroke in patients with stroke or transient
ischemic attack: a guideline for healthcare professionals from the Amer-
ican Heart Association/American Stroke Association. Stroke 2011;42:
227-76.
. Rockman CB, Maldonado TS, Jacobowitz GR, Cayne NS, Gagne PJ,
Riles TS. Early carotid endarterectomy in symptomatic patients is asso-
ciated with poorer perioperative outcomes. J Vasc Surg 2006;44:480-7.
